250
Participants
Start Date
January 29, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
May 31, 2027
Placebo
A substance that is designed to have no therapeutic value
MM120 (LSD D-Tartrate)
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)
RECRUITING
Sheppard Pratt Health System, Towson
ACTIVE_NOT_RECRUITING
Atlanta Center for Medical Research, Atlanta
RECRUITING
Clinical Neuroscience Solutions, Inc, Orlando
RECRUITING
Bradenton Research Center, Inc., Bradenton
RECRUITING
Neuro-Behavioral Clinical Research, Inc., North Canton
RECRUITING
University of Cincinnati Psychiatry- Anxiety Disorders Research Program, Cincinnati
RECRUITING
Preferred Research Partners, Inc., Little Rock
RECRUITING
Austin Clinical Trial Partners, Austin
RECRUITING
Cedar Clinical Research, Murray
RECRUITING
Psychedelic Science Institute, Los Angeles
NOT_YET_RECRUITING
West Los Angeles VA Medical Center, Los Angeles
ACTIVE_NOT_RECRUITING
Cenexel-CNS, Torrance
RECRUITING
Core Clinical Research, Everett
ACTIVE_NOT_RECRUITING
Adams Clinical Boston, Boston
RECRUITING
Princeton Medical Institute, Princeton
RECRUITING
A-shine s.r.o., Pilsen
RECRUITING
Institut Neuropsychiatricke Pece (INEP), Prague
RECRUITING
Psyon s.r.o., Prague
RECRUITING
CMME, Paris
RECRUITING
GHU Paris Psychiatrie et Neurosciences, Paris
RECRUITING
Department of Psychiatry and Psychotherapy Campus Charité Mitte Charité Universitätsmedizin Berlin, Berlin
RECRUITING
OVID Clinic Berlin, Berlin
RECRUITING
Central Institute of Mental Health, Mannheim
RECRUITING
Klinik für Psychiatrie und Psychotherapie, Abt: Allgemeine Psychiatrie und Psychotherapie, Tübingen
RECRUITING
Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk
RECRUITING
Clerkenwell Health - Baker Street, London
RECRUITING
Clerkenwell Health, London
RECRUITING
South London and Maudsley NHS Foundation Trust of The Maudsley Hospital, London
Mind Medicine, Inc.
INDUSTRY